Special Correspondent
Pune: In a significant development, recent water sample tests in Pune have revealed no presence of Campylobacter jejuni, the bacterium commonly linked to Guillain-Barré Syndrome (GBS). This finding has brought much-needed relief to health authorities amidst what is being described as the world’s largest GBS outbreak. The update was presented during a review meeting chaired by Divisional Commissioner Dr. C. Pulkundwar on Wednesday.
“This is a positive sign, suggesting the outbreak may be tapering off,” stated Dr. Nagnath Yempalle, Pune district civil surgeon. Health authorities have been instructed to closely monitor discharged patients for at least 21 days due to the disorder’s prolonged incubation period.
Reinforcing Preventive Measures
The meeting, held in response to the escalating health concerns, saw participation from municipal officials, Food and Drug Administration (FDA) representatives, medical officers, and scientists from the National Institute of Virology (NIV). Authorities conducted a detailed assessment of the situation and issued additional directives to strengthen preventive measures.
“Although the current tests only show the presence of E. coli and no Campylobacter jejuni, which triggers GBS, the Divisional Commissioner has urged us to remain vigilant,” said Dr. Yempalle.
To ensure ongoing safety, water testing will continue for the next four weeks until GBS cases are entirely eliminated. Water sources in high-risk areas are being chlorinated, and bleaching powder has been distributed to private tanker operators trained to follow World Health Organization (WHO) safety protocols.
Community and Medical Initiatives
Sixteen survey teams, comprising Auxiliary Nurse Midwives (ANMs), Multi-Purpose Workers (MPWs), and ASHA workers, have been deployed to cover over 19,000 households in affected areas. These teams are tasked with monitoring patients and providing medical assistance where needed.
Hospitals have also been directed to maintain adequate stocks of GBS-specific medications and provide free treatment for economically disadvantaged patients. “Major medical centres, including Sassoon Hospital, will offer Intravenous Immunoglobulin (IVIG) at no cost to those who cannot afford it,” said Dr. Pulkundwar.
Moving Towards Eradication
Dr. Pulkundwar emphasized the continued focus on eradicating GBS entirely. “We are monitoring every step taken by officials and are committed to eliminating this health threat,” he asserted.
As health authorities ramp up efforts to combat the outbreak, the recent test results offer hope for the community and a step closer to resolving the crisis.
